CARE

NEUTRALEarnings

Carter Bankshares, Inc.

2026-06-10

Price

$29.12

+1.39%

This is the 2026-06-10 snapshot — the signals and analysis for CARE as of this single trading day.

View full CARE research hub →

Score6.0Priority

Signals3/8 DNA0/13 Act · 0/4 Risk

SentimentNEUTRALScore: 8

Volume0.7xvs 20d avg

Analysis

Carter Bankshares (CARE) is undergoing a structural re-rating driven by massive balance sheet de-risking, which easily overrides headline algorithmic noise. Despite a reported core EPS miss for Q1, the stock has surged, confirming Institutional Absorption as the market digests a $289.5 million cash influx from offloading nonperforming legacy loans and an upcoming $35.8 million Q2 gain from selling its insurance unit. Backed by ALPHA_MALE and PERFECT_STACK technical signals, this High-Conviction Price Discovery is further amplified by the RISK_ON (GEOPOLITICAL) macro regime, which encourages capital rotation into clean, cash-rich regional bank value plays.

Fired Signals

ALPHA MALEGOLDEN CROSSPERFECT STACK

Key Takeaways

Balance Sheet Transformation: The $289.5M cash sale of nonperforming loans and the $35.8M Q2 gain from selling Bearing Insurance provide massive capital flexibility.
Institutional Absorption: The market completely ignored a core Q1 EPS miss, focusing instead on GAAP profitability, portfolio repositioning, and a radically derisked balance sheet.
High-Conviction Trend: Leading the SPY by +13.2% over the last month with GOLDEN_CROSS and PERFECT_STACK signals firing, CARE is firmly in a momentum-driven price discovery phase.

← Back to 2026-06-10 View Full CARE History →Yahoo Finance &nearr;